{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:53:06Z","timestamp":1782949986075,"version":"3.54.5"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,7]]},"DOI":"10.7759\/cureus.103151","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T12:30:16Z","timestamp":1770467416000},"source":"Crossref","is-referenced-by-count":1,"title":["Anti-PM\/Scl Antibody-Positive Dermatomyositis With Rapidly Progressive Interstitial Lung Disease in a 19-Year-Old Male: Clinical Implications of a Presumptive Diagnosis Based on Line Immunoassay Positivity"],"prefix":"10.7759","author":[{"given":"Nozomi","family":"Kawamata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Toumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Kon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Amano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/25785826.2024.2413604","article-title":"Myositis-specific and myositis-associated autoantibodies: their clinical characteristics and potential pathogenic roles","volume":"48","author":"Ogawa-Momohara M","year":"2025","unstructured":"Ogawa-Momohara M, Muro Y. Myositis-specific and myositis-associated autoantibodies: their clinical characteristics and potential pathogenic roles. Immunol Med. 2025, 48:104-16. 10.1080\/25785826.2024.2413604","journal-title":"Immunol Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2024.152536","article-title":"Clinical characteristics of idiopathic inflammatory myopathies patients with anti-PM\/Scl antibodies","volume":"68","author":"Zhu L","year":"2024","unstructured":"Zhu L, Zong C, Chen Y, Wang G, Ge Y. Clinical characteristics of idiopathic inflammatory myopathies patients with anti-PM\/Scl antibodies. Semin Arthritis Rheum. 2024, 68:152536. 10.1016\/j.semarthrit.2024.152536","journal-title":"Semin Arthritis Rheum"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25348","article-title":"2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) guideline for the treatment of interstitial lung disease in people with systemic autoimmune rheumatic diseases","volume":"76","author":"Johnson SR","year":"2024","unstructured":"Johnson SR, Bernstein EJ, Bolster MB, et al.. 2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) guideline for the treatment of interstitial lung disease in people with systemic autoimmune rheumatic diseases. Arthritis Care Res (Hoboken). 2024, 76:1051-69. 10.1002\/acr.25348","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/art.42860","article-title":"2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) guideline for the screening and monitoring of interstitial lung disease in people with systemic autoimmune rheumatic diseases","volume":"76","author":"Johnson SR","year":"2024","unstructured":"Johnson SR, Bernstein EJ, Bolster MB, et al.. 2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) guideline for the screening and monitoring of interstitial lung disease in people with systemic autoimmune rheumatic diseases. Arthritis Rheumatol. 2024, 76:1201-13. 10.1002\/art.42860","journal-title":"Arthritis Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.11389\/jjrs.14040174","article-title":"Three cases of anti-PM-Scl antibody-positive interstitial lung disease with differing clinical courses and imaging findings. (Article in Japanese)","volume":"14","author":"Shimizu Y","year":"2025","unstructured":"Shimizu Y, Kato S, Ikuta S, Yoneda M, Tabata E, Otani Y. Three cases of anti-PM-Scl antibody-positive interstitial lung disease with differing clinical courses and imaging findings. (Article in Japanese). Ann Japan Resp Soc. 2025, 14:174-9. 10.11389\/jjrs.14040174","journal-title":"Ann Japan Resp Soc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14999","article-title":"Aggressive multi-combination therapy for anti-MDA5 antibody-positive dermatomyositis-rapidly progressive interstitial lung disease","volume":"27","author":"Hata K","year":"2024","unstructured":"Hata K, Kotani T, Matsuda S, et al.. Aggressive multi-combination therapy for anti-MDA5 antibody-positive dermatomyositis-rapidly progressive interstitial lung disease. Int J Rheum Dis. 2024, 27:e14999. 10.1111\/1756-185X.14999","journal-title":"Int J Rheum Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2022.05.011","article-title":"256th ENMC international workshop: Myositis specific and associated autoantibodies (MSA-ab): Amsterdam, The Netherlands, 8-10 October 2021","volume":"32","author":"Damoiseaux J","year":"2022","unstructured":"Damoiseaux J, Mammen AL, Piette Y, Benveniste O, Allenbach Y. 256th ENMC international workshop: Myositis specific and associated autoantibodies (MSA-ab): Amsterdam, The Netherlands, 8-10 October 2021. Neuromuscul Disord. 2022, 32:594-608. 10.1016\/j.nmd.2022.05.011","journal-title":"Neuromuscul Disord"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa021","article-title":"The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity","volume":"59","author":"Tansley SL","year":"2020","unstructured":"Tansley SL, Li D, Betteridge ZE, McHugh NJ. The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity. Rheumatology (Oxford). 2020, 59:2109-14. 10.1093\/rheumatology\/keaa021","journal-title":"Rheumatology (Oxford)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13182929","article-title":"The autoantibody array assay: a novel autoantibody detection method","volume":"13","author":"Norimatsu Y","year":"2023","unstructured":"Norimatsu Y, Matsuda KM, Yamaguchi K, et al.. The autoantibody array assay: a novel autoantibody detection method. Diagnostics (Basel). 2023, 13:2929. 10.3390\/diagnostics13182929","journal-title":"Diagnostics (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1255540","article-title":"Comprehensive autoantibody profiling in systemic autoimmunity by a highly-sensitive multiplex protein array","volume":"14","author":"Kuzumi A","year":"2023","unstructured":"Kuzumi A, Norimatsu Y, Matsuda KM, et al.. Comprehensive autoantibody profiling in systemic autoimmunity by a highly-sensitive multiplex protein array. Front Immunol. 2023, 14:1255540. 10.3389\/fimmu.2023.1255540","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.03.007","article-title":"Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease","volume":"50","author":"Romero-Bueno F","year":"2020","unstructured":"Romero-Bueno F, Diaz Del Campo P, Trallero-Aragu\u00e1s E, et al.. Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease. Semin Arthritis Rheum. 2020, 50:776-90. 10.1016\/j.semarthrit.2020.03.007","journal-title":"Semin Arthritis Rheum"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/ncprheum0770","article-title":"Therapy insight: preserving fertility in cyclophosphamide-treated patients with rheumatic disease","volume":"4","author":"Dooley MA","year":"2008","unstructured":"Dooley MA, Nair R. Therapy insight: preserving fertility in cyclophosphamide-treated patients with rheumatic disease. Nat Clin Pract Rheumatol. 2008, 4:250-7. 10.1038\/ncprheum0770","journal-title":"Nat Clin Pract Rheumatol"},{"key":"ref13","article-title":"Cyclophosphamide-induced gonadal toxicity: a treatment dilemma in patients with lupus nephritis?","volume":"62","author":"Wetzels JF","year":"2004","unstructured":"Wetzels JF. Cyclophosphamide-induced gonadal toxicity: a treatment dilemma in patients with lupus nephritis?. Neth J Med. 2004, 62:347-52.","journal-title":"Neth J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2117912","article-title":"Trial of intravenous immune globulin in dermatomyositis","volume":"387","author":"Aggarwal R","year":"2022","unstructured":"Aggarwal R, Charles-Schoeman C, Schessl J, et al.. Trial of intravenous immune globulin in dermatomyositis. N Engl J Med. 2022, 387:1264-78. 10.1056\/NEJMoa2117912","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102997","article-title":"Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: a systematic review and meta-analysis","volume":"21","author":"Goswami RP","year":"2022","unstructured":"Goswami RP, Haldar SN, Chatterjee M, et al.. Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: a systematic review and meta-analysis. Autoimmun Rev. 2022, 21:102997. 10.1016\/j.autrev.2021.102997","journal-title":"Autoimmun Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/458232-anti-pmscl-antibody-positive-dermatomyositis-with-rapidly-progressive-interstitial-lung-disease-in-a-19-year-old-male-clinical-implications-of-a-presumptive-diagnosis-based-on-line-immunoassay-positivity","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T12:30:17Z","timestamp":1770467417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/458232-anti-pmscl-antibody-positive-dermatomyositis-with-rapidly-progressive-interstitial-lung-disease-in-a-19-year-old-male-clinical-implications-of-a-presumptive-diagnosis-based-on-line-immunoassay-positivity"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.103151","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,7]]}}}